PDS5B and non-small cell lung carcinoma: In non-small-cell lung carcinoma (NSCLC), lncRNA HOXA-AS3 interacted with HOXA3 and regulated EMT (epithelial-mesenchymal transition) and led to cisplatin resistance55.